课题基金 / 基金详情

HETEROGENEITY OF ALPHA-2 ADRENERGIC RECEPTORS

HETEROGENEITY OF ALPHA-2 ADRENERGIC RECEPTORS
ALPHA-2 肾上腺素能受体的异质性
批准号:
3298703
负责人:
DAVID B BYLUND
金额:
$17.0万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 1993-06-30

项目摘要

项目成果

DAVID B BYLUND的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Alpha-2 adrenergic receptors mediate several important functions of the endogenous catecholamines in both the central and peripheral nervous systems. Several clinically important drugs appear to produce their pharmacologic effects through an interaction at alpha-2 receptors. There now exists considerable evidence indicating significant differences in the pharmacological characteristics and regulation of mammalian alpha-2 adrenergic receptors from various tissues and species. We suggest that differences in the pharmacological properties and in the regulation (mechanism of action) of alpha-2 adrenergic receptors may be due to differences in the structure of the alpha-2 adrenergic receptor complex. To test this hypothesis, it is proposed to compare in various tissues and species: (1) The rank order and relative potencies of various adrenergic drugs using both radioligand binding and functional assays; (2) The thermal stability and pH optima of radioligand binding; (3) The functional size of the receptor complex using target analysis (radiation inactivation); (4) The apparent molecular size determined by gel filtration and sucrose density gradient centrifugation of receptor preparations solubilized in the presence and absence of agonist; and (5) The apparent molecular weight from SDS gel electrophoresis of partially purified receptors labeled with a photoaffinity probe. These studies should help to resolve the present confusion in classification of alpha receptors and may lead to more selective alpha adrenergic drugs for clinical use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Short Course: Integrative and Organ Systems Pharmacology
Short Course: Integrative and Organ Systems Pharmacology
Short Course: Integrative and Organ Systems Pharmacology
Short Course: Integrative and Organ Systems Pharmacology
国内基金
海外基金
CatS介导的HDAC6信号通路在慢性应激性血管内膜增生中的作用及分子机制
  • 批准号:
    82060052
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    33.0万元
  • 批准年份:
    2020
  • 负责人:
    李香
  • 依托单位:
猪12号染色体上新基因的CATS法分离及其定位和效应研究
  • 批准号:
    39870594
  • 项目类别:
    面上项目
  • 资助金额:
    16.0万元
  • 批准年份:
    1998
  • 负责人:
    李奎
  • 依托单位: